DK2155733T3 - Cykliske lactamer til behandling af glaukom eller forhøjet intraokulært tryk - Google Patents
Cykliske lactamer til behandling af glaukom eller forhøjet intraokulært trykInfo
- Publication number
- DK2155733T3 DK2155733T3 DK08755837.5T DK08755837T DK2155733T3 DK 2155733 T3 DK2155733 T3 DK 2155733T3 DK 08755837 T DK08755837 T DK 08755837T DK 2155733 T3 DK2155733 T3 DK 2155733T3
- Authority
- DK
- Denmark
- Prior art keywords
- glaucoma
- treatment
- intraocular pressure
- elevated intraocular
- cyclic lactams
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93977307P | 2007-05-23 | 2007-05-23 | |
| PCT/US2008/064073 WO2008144623A1 (en) | 2007-05-23 | 2008-05-19 | Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2155733T3 true DK2155733T3 (da) | 2012-10-29 |
Family
ID=39522202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08755837.5T DK2155733T3 (da) | 2007-05-23 | 2008-05-19 | Cykliske lactamer til behandling af glaukom eller forhøjet intraokulært tryk |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8198315B2 (da) |
| EP (1) | EP2155733B1 (da) |
| JP (1) | JP5524047B2 (da) |
| AU (1) | AU2008254717B2 (da) |
| BR (1) | BRPI0812385A2 (da) |
| CA (1) | CA2688897A1 (da) |
| CY (1) | CY1113448T1 (da) |
| DK (1) | DK2155733T3 (da) |
| ES (1) | ES2395875T3 (da) |
| PL (1) | PL2155733T3 (da) |
| PT (1) | PT2155733E (da) |
| SI (1) | SI2155733T1 (da) |
| WO (1) | WO2008144623A1 (da) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3167774D1 (en) | 1980-02-28 | 1985-01-31 | Fujisawa Pharmaceutical Co | 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics |
| GB2101114B (en) | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| US5212176A (en) | 1990-06-29 | 1993-05-18 | Abbott Laboratories | R(+)-terazosin |
| PL349839A1 (en) * | 1999-02-11 | 2002-09-23 | Pfizer Prod Inc | Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| DE60130675T2 (de) | 2000-11-27 | 2008-01-24 | Pfizer Products Inc., Groton | Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose |
| WO2003053923A2 (en) * | 2001-12-20 | 2003-07-03 | Applied Research Systems Ars Holding N.V. | Pyrrolidine derivatives as prostaglandin modulators |
| US7141597B2 (en) | 2003-09-12 | 2006-11-28 | Allergan, Inc. | Nonsedating α-2 agonists |
| NL1026830C2 (nl) * | 2004-08-12 | 2006-02-14 | Frederik Dirk Petrus Wolf | Vishaak. |
| ATE455760T1 (de) * | 2004-12-06 | 2010-02-15 | Merck Serono Sa | Pyrrolidin-2-on-derivate zur verwendung als dp1- rezeptoragonisten |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| BRPI0609021A2 (pt) | 2005-03-10 | 2010-01-12 | Allergan Inc | gama lactamas substituìdas, composição e uso das mesmas |
| US7772392B2 (en) | 2005-05-06 | 2010-08-10 | Allergan, Inc. | Therapeutic substituted β-lactams |
| ES2549863T3 (es) * | 2006-07-11 | 2015-11-02 | Allergan, Inc. | Derivados de ciclopentano como agentes antiglaucoma |
| ES2390323T3 (es) * | 2007-05-23 | 2012-11-08 | Allergan, Inc. | Compuestos terapéuticos de ((fenil)imidazolil)metilquinolinilo |
| NZ585103A (en) * | 2007-10-23 | 2012-04-27 | Allergan Inc | Substituted lactams derivatives and their uses for glaucoma and ocullar hypertension |
| US7902247B2 (en) * | 2008-01-09 | 2011-03-08 | Allergan, Inc. | Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors |
| US8063033B2 (en) | 2008-01-18 | 2011-11-22 | Allergan, Inc. | Therapeutic beta-lactams |
-
2008
- 2008-05-19 SI SI200830797T patent/SI2155733T1/sl unknown
- 2008-05-19 PT PT87558375T patent/PT2155733E/pt unknown
- 2008-05-19 DK DK08755837.5T patent/DK2155733T3/da active
- 2008-05-19 WO PCT/US2008/064073 patent/WO2008144623A1/en active Application Filing
- 2008-05-19 BR BRPI0812385A patent/BRPI0812385A2/pt not_active IP Right Cessation
- 2008-05-19 CA CA2688897A patent/CA2688897A1/en not_active Abandoned
- 2008-05-19 AU AU2008254717A patent/AU2008254717B2/en not_active Ceased
- 2008-05-19 JP JP2010509488A patent/JP5524047B2/ja not_active Expired - Fee Related
- 2008-05-19 PL PL08755837T patent/PL2155733T3/pl unknown
- 2008-05-19 EP EP08755837A patent/EP2155733B1/en not_active Not-in-force
- 2008-05-19 ES ES08755837T patent/ES2395875T3/es active Active
- 2008-05-19 US US12/600,723 patent/US8198315B2/en active Active
- 2008-05-21 US US12/600,757 patent/US8383646B2/en not_active Expired - Fee Related
-
2012
- 2012-12-10 CY CY20121101199T patent/CY1113448T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0812385A2 (pt) | 2019-09-24 |
| CA2688897A1 (en) | 2008-11-23 |
| SI2155733T1 (sl) | 2012-12-31 |
| ES2395875T3 (es) | 2013-02-15 |
| JP5524047B2 (ja) | 2014-06-18 |
| US20100190823A1 (en) | 2010-07-29 |
| US20100160407A1 (en) | 2010-06-24 |
| US8383646B2 (en) | 2013-02-26 |
| US8198315B2 (en) | 2012-06-12 |
| WO2008144623A1 (en) | 2008-11-27 |
| PT2155733E (pt) | 2013-01-07 |
| EP2155733A1 (en) | 2010-02-24 |
| CY1113448T1 (el) | 2016-06-22 |
| EP2155733B1 (en) | 2012-09-26 |
| AU2008254717A1 (en) | 2008-11-27 |
| AU2008254717B2 (en) | 2014-06-05 |
| PL2155733T3 (pl) | 2013-02-28 |
| JP2010528030A (ja) | 2010-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2300443T3 (da) | Triazolderivater, der er anvendelige til behandling af sygdomme | |
| DK3714877T3 (da) | Fremgangsmåde og sammensætning til behandling af okulær hypertension og glaukom | |
| DK3308769T3 (da) | Fremgangsmåder til fremstilling af cykliske lipidimplantater til intraokulær anvendelse | |
| DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
| DK1868600T3 (da) | Spirocyklisk cyclohexanderivat til behandling af stofafhængighed | |
| DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
| DK2448637T3 (da) | Anvendelse af ét fytocannabinoid eller en kombination af fytocannabinoider til behandling af epilepsi | |
| DK2808024T3 (da) | Bifidobakterier til behandling af kongestiv hjerteinsufficiens | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK2207775T3 (da) | 4-Benzylamino-1-carboxyacylpiperidinderivater som CETP-inhibitorer, som er anvendelige til behandling af sygdomme som hyperlipidæmi eller arteriosclerose | |
| DK2240130T3 (da) | Indretning til behandling af fedme | |
| DK2114886T3 (da) | Fremgangsmåde til fremstilling af visse substituerede sulfiliminer | |
| DK2349310T3 (da) | Polypeptid til behandling eller forebyggelse af adhæsioner | |
| FR2928832B1 (fr) | Orthese de poignet, destinee au traitement du syndrome du canal carpien | |
| DK2451482T3 (da) | Kombinationsterapi til behandlingen af diabetes | |
| DK2451796T3 (da) | Tofaanaloger til behandling af dermatologiske lidelser eller tilstande | |
| DK2146732T3 (da) | Fremgangsmåder til behandling eller forebyggelse af emese ved hjælp af væksthormonsekretagoger | |
| DK2459553T3 (da) | Furazanobenzimidazoler som prodrug til behandling af neoplastiske eller autoimmune sygdomme | |
| DK2148667T3 (da) | Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme | |
| DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
| DK2010184T3 (da) | Implatanter til behandlingen af dopamin associerede tilstande | |
| FR2913196B1 (fr) | Implant oculaire accomodatif | |
| DK1846354T3 (da) | Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande | |
| DK2382232T3 (da) | Fremgangsmåde til fremstilling af bivalirudin | |
| DK2321359T3 (da) | Fremgangsmåde til behandling af naturlige gummiprodukter |